ARCHIVES

Andrew von Eschenbach Sworn In As NCI Director.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

IVAX And It’s Portfolio

December 22, 1994

New Report On Survival Data Available From NCI

July 25, 1975

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

New NCI Journal Patterned On “Science”

March 20, 1987

NCI to Host SBIR Investor Forum

November 7, 2014